287 related articles for article (PubMed ID: 23070696)
1. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
Hess PL; Greiner MA; Fonarow GC; Klaskala W; Mills RM; Setoguchi S; Al-Khatib SM; Hernandez AF; Curtis LH
Clin Cardiol; 2012 Nov; 35(11):649-57. PubMed ID: 23070696
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
3. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims.
Hernandez AF; Hammill BG; Kociol RD; Eapen ZJ; Fonarow GC; Klaskala W; Mills RM; Curtis LH
J Card Fail; 2013 Jun; 19(6):401-7. PubMed ID: 23743489
[TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation.
Palamaner Subash Shantha G; Mentias A; Inampudi C; Kumar AA; Chaikriangkrai K; Bhise V; Deshmukh A; Patel N; Pancholy S; Horwitz PA; Mickelsen S; Bhave PD; Giudici M; Oral H; Vaughan Sarrazin MS
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862952
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.
Ghanbari H; Nallamothu BK; Wang Y; Curtis JP
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC
Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910
[TBL] [Abstract][Full Text] [Related]
9. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.
Coleman CI; Costa OS; Brescia CW; Vardar B; Abdelgawwad K; Sood N
Cardiovasc Diabetol; 2021 Feb; 20(1):52. PubMed ID: 33637082
[TBL] [Abstract][Full Text] [Related]
11. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
12. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
16. Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation.
Eapen ZJ; Mi X; Qualls LG; Hammill BG; Fonarow GC; Turakhia MP; Heidenreich PA; Peterson ED; Curtis LH; Hernandez AF; Al-Khatib SM
J Card Fail; 2014 Jan; 20(1):23-30. PubMed ID: 24275703
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
Genovesi S; Rebora P; Gallieni M; Stella A; Badiali F; Conte F; Pasquali S; Bertoli S; Ondei P; Bonforte G; Pozzi C; Rossi E; Valsecchi MG; Santoro A
J Nephrol; 2017 Aug; 30(4):573-581. PubMed ID: 27834042
[TBL] [Abstract][Full Text] [Related]
18. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.
Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG
Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074
[TBL] [Abstract][Full Text] [Related]
19. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
[TBL] [Abstract][Full Text] [Related]
20. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
